James B. Breitmeyer, CEO: Oncternal Therapeutics ONCT Buy · Filed 23/04/17

Trade details

Type: Insider buy
Amount: $29,000
Shares · price: 100,000 sh · $0.29 a share
Held after: 146,544 sh
Stock: Oncternal Therapeutics ONCT
Person: James B. BreitmeyerCEO
Trade date: 23/04/13
Filed: 23/04/17
Days to filing: 4 days

4 insiders bought this week

Insiders buying this week: 4 insiders
Holding change: +214.9%

Oncternal Therapeutics trades, last 26 weeks

What else happened in Oncternal Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/14~23/05/13

James B. Breitmeyer's recent trades

James B. BreitmeyerCEO
BuyOncternal Therapeutics
Buy
Oncternal Therapeutics
ONCT
$14.3K
47,750 sh
$14.3K
Filed 23/04/17
Traded 23/04/14
James B. BreitmeyerCEO
BuyOncternal Therapeutics
Buy
Oncternal Therapeutics
ONCT
$653
2,250 sh
$653
Filed 23/04/17
Traded 23/04/14